The precise mechanisms underlying the development of Crohn’s disease (CD) remain controversial, but sufficient data have been collected to suggest that an uncontrolled immune response within the intestinal mucosa leads to inflammation in a genetically susceptible host. Although lack of mucosal regulatory T cells causes colitis in humans and experimental rodents, patients with CD have more rather than less regulatory activity in the intestine, apparently excluding defects in tolerance as the cause of CD. Genome‐wide association studies have identified many gene variants that confer susceptibility and which seem associated to diminished functioning of especially innate immunity. In apparent agreement, CD patients are impaired with respect innate immune responses and controlling bacterial flora in the intestine. Furthermore, severe genetic deficiencies in innate immunity, like e.g. lack of NADPH oxidase activity or diminished function of the Wiskott Aldrich syndrome protein are associated with colitis in mice and men, and are often mistakenly diagnosed as CD. Thus we favour the view that the primary defect in CD is a lack in innate immunity, causing second tier immunological defences to combat otherwise easily controlled bacterial breaches of the mucosal barrier.

, , , , , , , , , , , ,
Financial support for this thesis defence was kindly provided by: Dr. Falk, Vifor Pharma, Erasmus University Rotterdam
M.P. Peppelenbosch (Maikel)
Erasmus University Rotterdam
hdl.handle.net/1765/41033
Erasmus MC: University Medical Center Rotterdam

Somasundaram, R. (2013, June 19). Action and Function of Neutrophils in Crohn`s Disease . Retrieved from http://hdl.handle.net/1765/41033